Who’s Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?
Eli Lilly’s GLP-1 drug is now the world’s best-selling drug. Novo Nordisk is struggling with declining market share.…
Pfizer clinches $10bn Metsera deal as Novo Nordisk retreats
One of the most compelling acquisition sagas in the pharma industry in recent times has come to an…
Why Weight-Loss Drug Prices Are Falling| Business News
President Trump claimed credit Thursday for cutting prices on popular weight-loss drugs by Eli Lilly and Novo Nordisk.…
Trump seeks lower prices for Wegovy, Zepbound
President Donald Trump announces plan to expand IVF access President Donald Trump announced a plan to expand IVF…
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and…
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and…
What will TrumpRx mean for patients? Who saves — and how much
Could “TrumpRx” be the prescription for lower drug prices? President Donald Trump announced a landmark deal with Pfizer…
Thousands of Australians fighting ‘cruel’ battle for COVID vaccine injury compensation
It’s almost the same every week. Take medication, check dosage, draw into needles, administer drugs. The only thing…
Pfizer’s strategy to support Vietnam’s national healthcare transformation
Vietnam is going through a transformation as the government is driving science and technology innovation through Resolution 57…
2 Undervalued Healthcare Stocks Poised to Dominate the Next Decade
Pfizer and Novo Nordisk have underperformed the market over the past year. But both should remain major players…
New recall of injected penicillin may put gains against syphilis in peril
Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting…